Cardiovascular

Main Content

L-citrulline Study

Study title

Phase 3, double-blind, randomixed, placebo-controlled multicenter clinical study to evaluate the efficacy and safety of intravenous L-citrulline for the prevention of clinical sequelae of acute lung injury induced by cardiopulmonary bypass in pediatric subjects undergoing surgery for congenital heart defects

  • Principal Investigator:  Dr. Mary Taylor

Purpose

This study is looking at a way to decrease the incidents of respiratory sequelae associated with cardio-pulmonary bypass during corrective surgery.

Who can participate

  • Patients ages 0-18 with an uncomplicated ASK/VSD, undergoing corrective surgery

For more information

  • Dana Lindsay, RN
    University of Mississippi Medical Center 
    2500 N. State St. 
    Jackson MS 39216 
    (601) 815-9480
  • IRB Number: 2017-0315